Lilly to Expand its Manufacturing Site in Ireland with USD 1.8 Billion Investment
The company also unveiled its new USD 800 million facility expansion in Kinsale, Ireland, which began making medicines last year to meet demand for Lilly's latest diabetes and obesity treatments.
Biologic Active Ingredients | 13/09/2024 | By Aishwarya
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy